FusePaq Synapryn and Moxetumomab pasudotox
Determining the interaction of FusePaq Synapryn and Moxetumomab pasudotox and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: tramadol
Brand name: ConZip, Ultram, Ultram ER, Rybix ODT, Ryzolt
Synonyms: Tramadol, TraMADol
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- FusePaq Synapryn-Moxetumomab Pasudotox-tdfk
- FusePaq Synapryn-Moxetumomab pasudotox-tdfk Intravenous
- FusePaq Synapryn-Moxifloxacin
- FusePaq Synapryn-Moxifloxacin (Systemic)
- FusePaq Synapryn-Moxifloxacin Hydrochloride
- FusePaq Synapryn-Moxifloxacin Injection
- Moxetumomab pasudotox-FusePaq Tabradol
- Moxetumomab pasudotox-Fusilev
- Moxetumomab pasudotox-Fusion
- Moxetumomab pasudotox-Fusion Plus (Vitamin B Complex and Iron Combinations Tablets and Capsules)
- Moxetumomab pasudotox-Fusion Plus (Vitamins (Multiple/Oral))
- Moxetumomab pasudotox-Fuzeon